Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration.

CONCLUSION: Aflibercept and ranibizumab were used at a similar frequency resulting in similar intravitreal anti-VEGF injection healthcare expenditures among wet AMD patients initiating first-line intravitreal anti-VEGF treatment.
PMID: 24310208 [PubMed - as supplied by publisher]

Source: Advances in Therapy - December 6, 2013 Category: Drugs & Pharmacology Authors: Johnston SS, Wilson K, Huang A, Smith D, Varker H, Turpcu A Tags: Adv Ther Source Type: research